Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. What is dihexa, its mechanism of action via the HGF c Met pathway, and its safety and clinical use? Public Meeting: FDA Rare Disease Day 2026 02 23 2026 FDA FDA Category 2 Update: The 5 Peptides Still Facing Heavy Review As excitement builds around peptides potentially moving off the FDA Category 2 list, it's important to understand one key reality: Not